BioCentury
ARTICLE | Clinical News

SmithKline regulatory update

April 15, 2013 7:00 AM UTC

The FDA granted marketing approval for Requip ropinirole to treat the signs and symptoms of Parkinson's disease. The product can be used as an initial therapy and as adjunctive treatment with levodo...